Yong Su

831 total citations
36 papers, 665 citations indexed

About

Yong Su is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Yong Su has authored 36 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Nephrology and 10 papers in Epidemiology. Recurrent topics in Yong Su's work include Ginseng Biological Effects and Applications (10 papers), Inflammasome and immune disorders (6 papers) and Chronic Kidney Disease and Diabetes (5 papers). Yong Su is often cited by papers focused on Ginseng Biological Effects and Applications (10 papers), Inflammasome and immune disorders (6 papers) and Chronic Kidney Disease and Diabetes (5 papers). Yong Su collaborates with scholars based in China, Saint Kitts and Nevis and United States. Yong Su's co-authors include Weizu Li, Weiping Li, Dujuan Xu, Yuli Han, Qingqing Chen, Quan Xia, Can Huang, Tianjiao Ji, Xianan Dong and Zhongyuan Wang and has published in prestigious journals such as Gene, Journal of Ethnopharmacology and Food and Chemical Toxicology.

In The Last Decade

Yong Su

32 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Su China 15 365 104 102 93 91 36 665
Lianbo Wei China 15 340 0.9× 112 1.1× 66 0.6× 93 1.0× 121 1.3× 33 731
Xiangchang Zeng China 15 366 1.0× 72 0.7× 146 1.4× 55 0.6× 86 0.9× 23 707
Jiangyi Yu China 13 199 0.5× 97 0.9× 48 0.5× 79 0.8× 82 0.9× 49 623
Xiaoyi Bao China 19 450 1.2× 41 0.4× 96 0.9× 197 2.1× 78 0.9× 26 911
Wenge Huang China 14 267 0.7× 53 0.5× 137 1.3× 54 0.6× 54 0.6× 33 658
Ang Ma China 13 266 0.7× 62 0.6× 38 0.4× 41 0.4× 78 0.9× 26 577
Xin Qin China 14 323 0.9× 103 1.0× 50 0.5× 29 0.3× 92 1.0× 37 826
Zhuyuan Fang China 12 210 0.6× 38 0.4× 55 0.5× 111 1.2× 48 0.5× 33 493
Yuxuan Kan China 14 236 0.6× 74 0.7× 57 0.6× 57 0.6× 95 1.0× 25 580

Countries citing papers authored by Yong Su

Since Specialization
Citations

This map shows the geographic impact of Yong Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Su more than expected).

Fields of papers citing papers by Yong Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Su. The network helps show where Yong Su may publish in the future.

Co-authorship network of co-authors of Yong Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Su. A scholar is included among the top collaborators of Yong Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Su. Yong Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Lei, Hong Liang, Xing Zhu, et al.. (2025). Ginsenoside Rg1 alleviates renal inflammation and fibrosis through regulating Nrf2-TRPC6 signalling pathway in mice. Journal of Functional Foods. 130. 106929–106929.
2.
3.
Zhang, Hui, Hong Liang, Lei Fan, et al.. (2025). Ginsenoside Rg1 attenuates T2DM-induced renal damage and fibrosis by inhibiting TRPC6-ChREBP-TXNIP signaling. Journal of Ethnopharmacology. 348. 119863–119863. 1 indexed citations
4.
Liu, Yan, Yong Su, Ran Sun, et al.. (2025). Knockout of Trpc6 attenuates T2DM-induced liver injury and inflammation by inhibiting CN-NFAT2-NLRP3 signalling in mice. Pathology - Research and Practice. 269. 155894–155894.
5.
Han, Min, Hui Zhang, Xiangyu Sun, et al.. (2024). Ginsenoside Rg1 alleviates diabetic liver injury and fibrosis by inhibiting the PLC-NFAT2-NLRP3 signaling pathway in T2DM mice. Journal of Functional Foods. 121. 106455–106455. 1 indexed citations
6.
Sun, Xiangyu, et al.. (2024). PLC-CN-NFAT1 signaling-mediated Aβ and IL-1β crosstalk synergistically promotes hippocampal neuronal damage. International Immunopharmacology. 134. 112259–112259. 1 indexed citations
7.
Sun, Ran, Min Han, Yan Liu, et al.. (2023). Trpc6 knockout protects against renal fibrosis by restraining the CN‑NFAT2 signaling pathway in T2DM mice. Molecular Medicine Reports. 29(1). 6 indexed citations
8.
Dong, Xianan, Liangliang Kong, Lei Huang, et al.. (2022). Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC–CN–NFAT1 signaling in T2DM mice. Journal of Ginseng Research. 47(3). 458–468. 11 indexed citations
9.
Han, Yuli, Yong Su, Min Han, et al.. (2022). Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice. Journal of Ethnopharmacology. 302(Pt A). 115923–115923. 34 indexed citations
10.
Liu, Yang, Huimin Zhou, Lei Huang, et al.. (2022). Stress level of glucocorticoid exacerbates neuronal damage and Aβ production through activating NLRP1 inflammasome in primary cultured hippocampal neurons of APP-PS1 mice. International Immunopharmacology. 110. 108972–108972. 13 indexed citations
11.
Deng, Yiyun, et al.. (2022). Mycophenolic Acid Induces the Intestinal Epithelial Barrier Damage through Mitochondrial ROS. Oxidative Medicine and Cellular Longevity. 2022(1). 4195699–4195699. 13 indexed citations
12.
Liu, Yang, Lei Huang, Liangliang Kong, et al.. (2022). Chronic glucocorticoid exposure accelerates Aβ generation and neurotoxicity by activating calcium-mediated CN-NFAT1 signaling in hippocampal neurons in APP/PS1 mice. Food and Chemical Toxicology. 168. 113407–113407. 11 indexed citations
13.
Yang, Chunlan, et al.. (2021). Glutaric Acidemia, Pathogenesis and Nutritional Therapy. Frontiers in Nutrition. 8. 704984–704984. 14 indexed citations
14.
Wu, Lijun, et al.. (2021). PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression. International Immunopharmacology. 94. 107443–107443. 44 indexed citations
15.
Su, Yong, Qingqing Chen, Tianjiao Ji, et al.. (2018). Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression. Pharmacological Reports. 71(2). 319–329. 38 indexed citations
16.
17.
Su, Yong, Qingqing Chen, Tianjiao Ji, et al.. (2018). Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats. Biomedicine & Pharmacotherapy. 109. 84–92. 82 indexed citations
18.
Su, Yong, Yali Su, Lifang Lv, et al.. (2014). A randomized controlled clinical trial of vildagliptin plus metformin combination therapy in patients with type II diabetes mellitus. Experimental and Therapeutic Medicine. 7(4). 799–803. 9 indexed citations
19.
Liu, Jiang & Yong Su. (2010). The of clinical effect of Shengmai injection on dialysis-related hypotension. 4(12). 62–63. 1 indexed citations
20.
Liu, Shuangxin, Wei Shi, Xinling Liang, et al.. (2010). Cellulose Triacetate Dialyzer Reduces Platelet Loss during Continuous Veno-Venous Hemofiltration. Blood Purification. 29(4). 375–382. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianbo Wei Breakdown of academic impact, for papers by Xiangchang Zeng Breakdown of academic impact, for papers by Jiangyi Yu Breakdown of academic impact, for papers by Xiaoyi Bao Breakdown of academic impact, for papers by Wenge Huang Breakdown of academic impact, for papers by Ang Ma Breakdown of academic impact, for papers by Xin Qin Breakdown of academic impact, for papers by Zhuyuan Fang Breakdown of academic impact, for papers by Yuxuan Kan
Rankless by CCL
2026